title: Adverse events of subcutaneous recombinant human erythropoietin therapy.
authors.affiliation: Department of Internal Medicine, University of Rostock, FRG.
authors.forename: H
authors.initials: H
authors.lastname: Klinkmann
authors.forename: R
authors.initials: R
authors.lastname: Schmidt
authors.forename: L
authors.initials: L
authors.lastname: Wieczorek
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
mesh_terms: D002319:Cardiovascular System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D008297:Male; D006435:Renal Dialysis; D012137:Respiratory System / Q000187:drug effects; D012449:Safety
chemical_list: D004921:Erythropoietin